Hang Seng Hits 19-Month Low as Tech Earnings Disappoint

Hong Kong's Hang Seng Index fell to its lowest level in about 19 months on Friday, closing 1.89 per cent lower at 22,410.80 as disappointing earnings from Chinese technology companies deepened a sell-off driven by doubts about artificial intelligence spending.
The benchmark lost 430.82 points in its fourth consecutive daily decline and has now fallen 5.19 per cent, or 1,226.80 points, over the week. The Hang Seng Tech Index dropped 3.78 per cent to 3,511.14, while turnover reached HK$270.3 billion.
NetEase and Kuaishou plunge on earnings
NetEase plunged 17.6 per cent to HK$154 after reporting a 3.6 per cent fall in adjusted net profit to RMB 8.4 billion, alongside an unusual 1.7 per cent contraction in gaming revenue.
Kuaishou fell 11.4 per cent to HK$20.42 after its third-quarter adjusted net profit dropped 84.16 per cent from a year earlier to RMB 790 million, and it posted a net loss attributable to shareholders of RMB 961 million.
The two results hit a market already nervous about the returns on AI investment. Hong Kong-listed shares of Chinese AI model developers also tumbled: Minimax slumped 10.8 per cent to record lows, taking its loss for the week past 30 per cent, while Z.AI declined 7.2 per cent, extending its weekly loss to 18.2 per cent.
Alibaba bucks the trend
Alibaba was the notable exception, rising 3.5 per cent to HK$83.35 after reporting that adjusted earnings before interest, tax, depreciation and amortisation for the quarter to 30 September rose 260 per cent from a year earlier.
Tencent, the social media giant, fell 1.3 per cent to HK$344, its lowest range since July 2024. Baidu dropped 4 per cent to HK$64.05, Xiaomi fell 3.1 per cent to HK$27.64 and Meituan declined 1.6 per cent to HK$66.50.
Chip and drug stocks also hit
Semiconductor shares were among the biggest drags, with a sub-index tracking the sector down 3.9 per cent. Hua Hong Semiconductor plunged 10.2 per cent to HK$75.10 and SMIC fell 2.7 per cent to HK$49.12.
Pharmaceutical stocks also came under pressure, with Innovent Biologics down 6.3 per cent, WuXi Biologics 6.6 per cent lower and Hansoh Pharmaceutical falling 5.2 per cent.
The selling in Hong Kong followed a steep Wall Street sell-off and came despite Anthropic's record initial public offering, which did little to revive confidence in the AI trade. Investors will now watch whether mainland markets stabilise next week or whether the selling spreads further.